跳至主要内容
临床试验/NCT04806607
NCT04806607已完成不适用

19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB): A Randomized Prospective Trial

Geisinger Clinic2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2021年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
2
主要终点
Length of Longest Piece

研究概览

简要总结

To determine the adequacy of EUS-LB using a 19G core needle compared to a 22G core needle in a prospective randomized study.

详细描述

The 19Gauge core and 22Gauge core needles have both been used for EUS-LB with good success. Previous studies have reported good safety and tissue adequacy with both the needles, but the head-on comparison between these two needles is lacking.

This is a prospective randomized trial comparing the biopsy specimen adequacy of 19Gauge versus 22Gauge core needles for EUS-LB.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing EUS-LB
  • Platelet Count > 50,000
  • International normalized ratio (INR) < 1.5
  • Age > 18 years of age
  • Non-Pregnant Patients

排除标准

  • Age < 18 Years of Age
  • Pregnant Patients
  • Inability to obtain consent
  • Anticoagulants or anti-platelet agents (excluding aspirin) within the last 7 -10 days
  • Platelet count < 50,000
  • Presence of Ascites
  • Known Liver Cirrhosis

结局指标

主要结局

Length of Longest Piece

时间窗: Up to 5 Days

Length of the longest piece of the liver tissue obtained

次要结局

  • Adverse Events and Serious Adverse Events(7 to 10 Days Post Procedure)
  • Aggregate Specimen Length(3 to 5 Days)
  • Degree of Fragmentation(3 to 5 Days)
  • Number of Portal Tracts in the Specimen(3 to 5 Days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David L. Diehl

Principal Investigator

Geisinger Clinic

研究点 (2)

Loading locations...

相似试验